Meanwhile, oxidized HMGB1 may trigger CD274/PD-L1 expression in an AGER-dependent manner, thereby allowing tumors to evade anticancer immunosurveillance in PC cells [32]. The gene discussed is HMGB1; the disease is pachyonychia congenita.